← SynDRA
LINOPIRDINE
SynDRA canonical compound SYN0003870 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | KCNQ3 |
|---|
| Mechanism of action | Potassium channel blocker |
|---|
All known targets
- KCNQ2
- KCNQ3
- KCNQ4
- KCNQ5
- Kcnq1
- Kcnq3
Mechanisms of action (all sources)
- Potassium channel blocker
- KCNQ2 MODULATOR
- KCNQ4 MODULATOR
- KCNQ5 MODULATOR
- KCNQ3 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- DRD1
- TDP1
- PTH1R
- MAPK1
- HDAC6
- GMNN
- EHMT2
- CYP3A4
- APEX1
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- BAZ2B
- ATXN2
- THPO
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- ALOX12
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
- LOX12
Drug classes
- Cardiovascular Agents
- Central Nervous System Agents
- Membrane Transport Modulators
- Neuroprotective Agents
- Potassium Channel Blockers
- Protective Agents
ATC classes
- N06B · PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
Cross-references
Synonyms
- Linopirdina
- DUP-996
- AVIVA
- Linopirine
- DuP-996
- 1-phenyl-3,3-bis(pyridin-4-ylmethyl)indol-2-one
- I5TB3NZ94T
- 1-phenyl-3,3-bis(4-pyridylmethyl)indolin-2-one
- 3,3-bis(4-pyridylmethyl)-1-phenylindolin-2-one
- linopirdinum
- 3,3-dipyridylmethyl-1-phenyl-2-indolinone
- RefChem:924805
- N06BX09
- 1-Phenyl-3,3-bis(pyridin-4-ylmethyl)indolin-2-one
- MFCD00867216
- 1-Phenyl-3,3-bis(4-pyridinylmethyl)-2-indolinone
- NCGC00015590-03
- DTXCID4025163
- Linopirdine [USAN:INN]
- CAS-105431-72-9
- UNII-I5TB3NZ94T
- SR-01000075324
- Tocris-1999
- Lopac-L-134
- Linopirdine(DuP-996)
- LINOPIRDINE [INN]
- Linopirdine (USAN/INN)
- LINOPIRDINE [USAN]
- LINOPIRDINE [MART.]
- Lopac0_000732
- LINOPIRDINE [WHO-DD]
- MLS000862189
- SCHEMBL122699
- GTPL2599
- orb1308125
- CHEBI:34823
- Linopirdine, >=98% (HPLC)
- YEJCDKJIEMIWRQ-UHFFFAOYSA-N
Look up LINOPIRDINE in the interactive SynDRA portal →